DRDGOLD manager sells 9,029 shares at $2.75

Q: What insider transactions did DRD’s Financial Manager report on this Form 4?

The filing reports that Financial Manager FWGR Ops. Laas Lihan had 9,029 Deferred Shares vest and settle into Ordinary Shares on August 13, 2026, and then sold 9,029 Ordinary Shares in a pooled transaction on August 31 and September 1, 2026.

Q: How many DRD Ordinary Shares were sold and at what price?

A total of 9,029 Ordinary Shares of DRDGOLD LTD were sold as part of a pooled sale on August 31 and September 1, 2026 at an average price of $2.7545 per share, based on a transaction originally denominated in South African rand at ZAR 44.4764 per share.

Q: What happened to the Deferred Shares reported for DRD’s insider?

On August 13, 2026, 9,029 Deferred Shares previously awarded under DRDGOLD’s Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration, as disclosed in the footnotes.

Q: Were the DRD insider’s trades executed under a Rule 10b5-1 trading plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan; the document-level checkbox is not marked as being pursuant to such a plan, and the footnotes do not state that the transactions were made under a pre-arranged trading arrangement.

Q: Does the Form 4 show the insider’s remaining holdings of Deferred Shares in DRD?

A footnote states that Table II, Column 9 reflects the current holdings of Deferred Shares after a subsequent acquisition previously reported on a Form 4 dated August 27, 2026, but the specific number is referenced there, not detailed again in this description.

DRDGOLD’s financial manager converted 9,029 deferred share awards into Ordinary Shares and sold the same number in a pooled market transaction.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

DRDGOLD LTD (DRD) reported that Financial Manager FWGR Ops. Laas Lihan exercised and sold equity-based awards. On August 13, 2026, 9,029 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration under the Single Incentive Plan. A pooled sale then disposed of 9,029 Ordinary Shares on August 31 and September 1, 2026 at an average of $2.7545 (ZAR 44.4764) per share. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Laas Lihan

Role Financial Manager FWGR Ops.

Sold 9,029 shs ($25K)

Approx. gross sale proceeds $25K

Approx. exercise cost $0.00

Type	Security	Shares	Price	Value
Sale	Ordinary Shares ^{F2, F3}	9,029	$2.7545	$25K
Exercise	Deferred Shares ^{F1, F4}	9,029	$0.00	$0.00
Grant/Award	Ordinary Shares ^F1	9,029	$0.00	$0.00

Holdings After Transaction: Deferred Shares — 47,112 contracts (Direct); Ordinary Shares — 0 shares (Direct)

Footnotes (4)

F1. On August 13, 2026, 9,029 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
F2. Represents 9,029 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 9,029 Deferred Shares described in footnote 1.
F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Key Figures

Ordinary Shares sold: 9,029 shares Average sale price: $2.7545 per Ordinary Share Average sale price in ZAR: ZAR 44.4764 per Ordinary Share +2 more

5 metrics

Ordinary Shares sold 9,029 shares Pooled sale conducted on August 31 and September 1, 2026

Average sale price $2.7545 per Ordinary Share Converted from ZAR using South African Reserve Bank rate on transaction date

Average sale price in ZAR ZAR 44.4764 per Ordinary Share Underlying transaction denominated in South African rand

Deferred Shares vested and settled 9,029 shares Vested on August 13, 2026 and settled one-for-one into Ordinary Shares

Exercise or conversion price $0.00 per Deferred Share Deferred Shares settled into Ordinary Shares for no consideration

Key Terms

Deferred Shares, Single Incentive Plan, pooled sale, Ordinary Shares

4 terms

Deferred Shares financial

"9,029 deferred shares of DRDGOLD Limited previously awarded to the Reporting Person"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Single Incentive Plan financial

"previously awarded to the Reporting Person under the Company's Single Incentive Plan"

pooled sale financial

"sold on behalf of the Reporting Person as part of a pooled sale conducted"

Ordinary Shares financial

"were settled on a one-for-one basis in Ordinary Shares for no consideration"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did DRD’s Financial Manager report on this Form 4?

The filing reports that Financial Manager FWGR Ops. Laas Lihan had 9,029 Deferred Shares vest and settle into Ordinary Shares on August 13, 2026, and then sold 9,029 Ordinary Shares in a pooled transaction on August 31 and September 1, 2026.

How many DRD Ordinary Shares were sold and at what price?

A total of 9,029 Ordinary Shares of DRDGOLD LTD were sold as part of a pooled sale on August 31 and September 1, 2026 at an average price of $2.7545 per share, based on a transaction originally denominated in South African rand at ZAR 44.4764 per share.

What happened to the Deferred Shares reported for DRD’s insider?

On August 13, 2026, 9,029 Deferred Shares previously awarded under DRDGOLD’s Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration, as disclosed in the footnotes.

Were the DRD insider’s trades executed under a Rule 10b5-1 trading plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan; the document-level checkbox is not marked as being pursuant to such a plan, and the footnotes do not state that the transactions were made under a pre-arranged trading arrangement.

Does the Form 4 show the insider’s remaining holdings of Deferred Shares in DRD?

A footnote states that Table II, Column 9 reflects the current holdings of Deferred Shares after a subsequent acquisition previously reported on a Form 4 dated August 27, 2026, but the specific number is referenced there, not detailed again in this description.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 05:01 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:46 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Laas Lihan

(Last)

(First)

(Middle)

CYCAD HOUSE, BUILDING 17, GROUND FLOOR

CNR 14TH AVENUE AND HENDRIK POTGIETER RD

(Street)

WELTEVREDEN PARK

1709

(City)

(State)

(Zip)

SOUTH AFRICA

(Country)

2. Issuer Name and Ticker or Trading Symbol
DRDGOLD LTD [ DRD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Financial Manager FWGR Ops.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/13/2026		A		9,029⁽¹⁾	A	$0	9,029	D
Ordinary Shares	09/01/2026		S		9,029⁽²⁾	D	$2.7545⁽³⁾	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Shares	$0	08/13/2026		M			9,029⁽¹⁾	⁽¹⁾	⁽¹⁾	Ordinary Shares	9,029	$0	47,112⁽⁴⁾	D

Explanation of Responses:

1. On August 13, 2026, 9,029 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.

2. Represents 9,029 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 9,029 Deferred Shares described in footnote 1.

3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.

4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Remarks:

	/s/ Lihan Laas	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR